{
    "clinical_study": {
        "@rank": "48757", 
        "arm_group": [
            {
                "arm_group_label": "Selective procedure", 
                "arm_group_type": "Active Comparator", 
                "description": "Selective laser photocoagulation of communicating vessels."
            }, 
            {
                "arm_group_label": "Sequential procedure", 
                "arm_group_type": "Experimental", 
                "description": "Sequential laser photocoagulation of communicating vessels"
            }
        ], 
        "brief_summary": {
            "textblock": "The investigators hypothesize that treatment of twin-twin transfusion syndrome (TTTS) using\n      sequential laser photocoagulation of communicating vessels (SQLPCV) over the predominant\n      method, selective laser photocoagulation of communicating vessels (SLPCV), may provide\n      vascular stability to the donor fetus. The primary objective is to evaluate the perinatal\n      outcome, specifically, donor intrauterine survival of TTTS managed by SQLPCV vs. SLPCV in a\n      prospective, randomized trial."
        }, 
        "brief_title": "Sequential vs. Standard Laser Treatment of Twin-twin Transfusion Syndrome", 
        "completion_date": {
            "#text": "June 2017", 
            "@type": "Anticipated"
        }, 
        "condition": "Twin Twin Transfusion Syndrome", 
        "condition_browse": {
            "mesh_term": "Fetofetal Transfusion"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Gestational age: 16 weeks, 0 days to 26 weeks, 0 days.\n\n          -  Confirmed TTTS patients, who by definition meet the following sonographic criteria:\n\n               -  Single placenta.\n\n               -  Polyhydramnios: maximum vertical pocket \u2265 8 cm in the recipient twin, prior to\n                  amniodrainage.\n\n               -  Oligohydramnios: maximum vertical pocket \u2264 2 cm in the donor twin, prior to\n                  amniodrainage.\n\n               -  Thin dividing membrane (absence of twin peak sign) or absence of dividing\n                  membrane (monoamniotic).\n\n               -  Same gender, if visible.\n\n               -  Quintero Stages 1-4.\n\n          -  Patients choosing laser therapy that have undergone prior therapeutic amniocentesis\n             may be included.\n\n          -  Patients with an anterior placenta may be included.\n\n          -  Triplet gestations with two or three fetuses sharing the same placenta may be\n             included.\n\n          -  Patients must be able to give written informed consent.\n\n        Exclusion Criteria:\n\n          -  Patients unable or unwilling to participate in the study or to be followed up.\n\n          -  Patients unable to give written informed consent.\n\n          -  Presence of major congenital anomalies that may not warrant surgery.\n\n          -  Known unbalanced chromosomal complement.\n\n          -  Prior intentional septostomy (purposely making a hole in the dividing membrane).\n\n          -  Ruptured membranes.\n\n          -  Chorioamnionitis.\n\n          -  Abnormal intracranial ultrasound findings of either fetus to include, but not limited\n             to: intraventricular hemorrhage, porencephalic cysts, hydrocephalus, Dandy-Walker\n             syndrome, holoprosencephaly and agenesis of the corpus callosum. Isolated\n             ventriculomegaly (atrium 10-19 mm) may or may not be used as exclusion criteria.\n\n          -  Placental abruption.\n\n          -  Active labor.\n\n          -  Patient unwilling to receive blood products.\n\n          -  Recipient twin with a middle cerebral artery peak systolic velocity > 1.5 multiples\n             of the median (indicative of fetal anemia).\n\n          -  Any other patient deemed inappropriate for the study by the principal investigator."
            }, 
            "gender": "Female", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "55 Years", 
            "minimum_age": "16 Years"
        }, 
        "enrollment": {
            "#text": "542", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 16, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02122328", 
            "org_study_id": "HS-09-00680"
        }, 
        "intervention": [
            {
                "arm_group_label": "Sequential procedure", 
                "intervention_name": "Sequential laser photocoagulation of communicating vessels.", 
                "intervention_type": "Procedure"
            }, 
            {
                "arm_group_label": "Selective procedure", 
                "intervention_name": "Selective laser photocoagulation of communicating vessels", 
                "intervention_type": "Procedure"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "Twin twin transfusion syndrome", 
            "Sequential laser photocoagulation of communicating vessels"
        ], 
        "lastchanged_date": "April 22, 2014", 
        "location": {
            "contact": {
                "email": "chmait@usc.edu", 
                "last_name": "Ramen Chmait, MD", 
                "phone": "323-361-6074"
            }, 
            "contact_backup": {
                "email": "allanes@usc.edu", 
                "last_name": "Arlyn Llanes, RN", 
                "phone": "323-361-6074"
            }, 
            "facility": {
                "address": {
                    "city": "Los Angeles", 
                    "country": "United States", 
                    "state": "California", 
                    "zip": "90027"
                }, 
                "name": "Hollywood Presbyterian Medical Center"
            }, 
            "investigator": {
                "last_name": "Ramen Chmait, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "USFetus Randomized Clinical Trial: Sequential vs. Standard Laser Treatment of Twin-twin Transfusion Syndrome", 
        "other_outcome": {
            "measure": "Fetal/neonatal/infant outcomes", 
            "safety_issue": "Yes", 
            "time_frame": "Birth to 6 months of life"
        }, 
        "overall_contact": {
            "email": "chmait@usc.edu", 
            "last_name": "Ramen Chmait, MD", 
            "phone": "323-361-6074"
        }, 
        "overall_contact_backup": {
            "email": "allanes@usc.edu", 
            "last_name": "Arlyn Llanes, RN", 
            "phone": "323-361-6074"
        }, 
        "overall_official": {
            "affiliation": "University of Southern California", 
            "last_name": "Ramen Chmait, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "June 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "A comparison of donor survival at birth will be made between subjects assigned to the sequential (SQLPCV) procedure versus those assigned to the selective (SLPCV) procedure.", 
            "measure": "To compare donor intrauterine survival (alive at birth) for those undergoing SQLPCV vs. SLPCV.", 
            "safety_issue": "Yes", 
            "time_frame": "Birth"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02122328"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University of Southern California", 
            "investigator_full_name": "Ramen Chmait", 
            "investigator_title": "Assistant Professor, Clinical Obstetrics & Gynecology, Pediatrics, and Surgery", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "measure": "Surgical complications", 
            "safety_issue": "Yes", 
            "time_frame": "21 post-operative days"
        }, 
        "source": "University of Southern California", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University of Southern California", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "June 2010", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}